Clinical Trial Update: Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of donepezil hydrochloride (Aricept) for vascular dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Dementia

Drugs mentioned

• Aricept (Donepezil)

Snippet

Sponsor: Eisai Inc. | Conditions: Vascular Dementia | Phase 4 | Status: COMPLETED